Skip to content
  • News
  • Anal Cancer
  • Bladder Cancer
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer of Unknown Primary
  • Cervical Cancer
  • Colon Cancer
  • Esophageal Cancer
  • Gastric Cancer
  • GIST
  • Head & Neck Cancer
  • Hodgkins Lymphoma
  • Leukemia
    • Acute Leukemia
    • Chronic Lymphocytic Leukemia
    • Chronic Myeloid Leukemia
  • Liver Cancer
  • Lung Cancer
  • Melanoma
  • Mesothelioma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • MPN-PV-ET-MF
  • Neuroblastoma
  • Neuroendocrine Tumors
  • Non Hodgkins Lymphoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cancer
  • Rectal Cancer
  • Sarcoma
  • Skin Care
  • Skin Cancer
  • Testicular Cancer
  • Thyroid Cancer
  • Triple Negative Breast Cancer
  • Uterine Cancer
  • About Us
  • Advertising
  • News
  • Newly Diagnosed
  • Treatment & Care
  • Survivorship
  • Join the Community
  • Newsletter

Renal Cancer

  • Targeted Therapy and Renal Cell Carcinoma: Are We Making Progress?
    June 1, 2018

    Targeted Therapy and Renal Cell Carcinoma: Are We Making Progress?

    Dr. C H Weaver MD
  • Everolimus Improves Progression-Free Survival in Kidney Cancer
    June 1, 2018

    Everolimus Improves Progression-Free Survival in Kidney Cancer

    Dr. C H Weaver MD
  • Cardiac Toxicity in Patients with MRCC Receiving Tyrosine Kinase Inhibitors
    June 1, 2018

    Cardiac Toxicity in Patients with MRCC Receiving Tyrosine Kinase Inhibitors

    Dr. C H Weaver MD
  • Neovastat Doubles Survival Time for Patients with Advanced Renal Cancer
    June 1, 2018

    Neovastat Doubles Survival Time for Patients with Advanced Renal Cancer

    Dr. C H Weaver MD
  • Nexavar® Improves Progression-free Survival in Advanced Kidney Cancer
    June 1, 2018

    Nexavar® Improves Progression-free Survival in Advanced Kidney Cancer

    Dr. C H Weaver MD
  • Addition of Erbitux® to XELOX Reduces Cancer Progression as First-line Therapy
    June 1, 2018

    Addition of Erbitux® to XELOX Reduces Cancer Progression as First-line Therapy

    Dr. C H Weaver MD
  • Surgery Prior to Interferon Improves Survival in Advanced Renal Cell Carcinoma
    June 1, 2018

    Surgery Prior to Interferon Improves Survival in Advanced Renal Cell Carcinoma

    Dr. C H Weaver MD
  • Drinking More Fluids May Reduce the Risk for Bladder Cancer in Men
    June 1, 2018

    Drinking More Fluids May Reduce the Risk for Bladder Cancer in Men

    Dr. C H Weaver MD
  • New Treatments Improve Outcomes for Metastatic Kidney Cancer
    June 1, 2018

    New Treatments Improve Outcomes for Metastatic Kidney Cancer

    Dr. C H Weaver MD
  • FDA Approves Torisel™ For Kidney Cancer
    June 1, 2018

    FDA Approves Torisel™ For Kidney Cancer

    Dr. C H Weaver MD
  • Adhesive Instead of Stitches May Reduce Surgery Complications in Kidney Cancer
    June 1, 2018

    Adhesive Instead of Stitches May Reduce Surgery Complications in Kidney Cancer

    Dr. C H Weaver MD
  • High Levels of Survivin Associated with Poorer Survival in Renal Cell Carcinoma
    June 1, 2018

    High Levels of Survivin Associated with Poorer Survival in Renal Cell Carcinoma

    Dr. C H Weaver MD
Previous Page
1 … 7 8 9 10 11
Next Page
  • Sitemap
  • About Us
  • Advertising
  • Privacy Policy

Loading Comments...